Absci is a pioneering biotechnology company that leverages generative artificial intelligence (AI) for drug creation. The company has made significant strides in the industry, including the development and validation of de novo antibodies using zero-shot generative AI, a major milestone in biotechnology.
The company has entered into several notable collaborations, including one with a Google Ventures-backed biotech company to discover innovative new medicines and another with Caltech, supported by the Gates Foundation, to discover affordable HIV therapeutic vaccinations. Absci continues to participate in significant events such as the Morgan Stanley 2nd Annual Biotechnology AI Summit and the UBS MedTech, Tools and Genomics Summit 2023.